论文部分内容阅读
1989～1992年,我们对80例气道阻塞性疾病患者,使用β_2-受体兴奋剂喘乐宁进行药物定量吸入可逆性缓解试验,通过肺功能检测项目FEV_1、V_(50)判断其试验结果,现报告如下。1.试验对象:随机选择肺功能检测基
From 1989 to 1992, 80 patients with obstructive airway disease were treated with β 2 -receptor agonist salbutamol for quantitative inhalation reversal remission test. The results of pulmonary function test FEV_1, V_ (50) The report is as follows. 1. Subjects: Random selection of lung function test base